7/16/2024
Question: Are the incentive metrics supposed to be achievable or stretch objectives? Answer: Incentive metrics should be defined to be achievable, and should also reward accomplishments that are above and…
7/16/2024
Clinical and ambulatory leadership will help you resolve recurring conflicts during your scheduled clinic times. For example, if you have an obligation in the School of Medicine that conflicts with…
UVA Health, The Haven Partner to Improve Opioid-Use Disorder Care
7/16/2024
UVA Health and The Haven—a multi-resource day shelter and housing resource center in Charlottesville—are partnering to provide opioid-use disorder care for unhoused members of the community. Backed by a grant…
New DNA Replication Questions Could Have Implications for Cancer
7/16/2024
New University of Virginia School of Medicine research is raising questions about how our DNA begins to replicate both in healthy cells and in cancer. DNA is the genetic material…
7/16/2024
What is NOWS Neonatal Opioid Withdrawal Syndrome (NOWS), also known as Neonatal Abstinence Syndrome (NAS), affects newborns exposed to opioids in utero, leading to withdrawal symptoms such as tremors, irritability,…
Clint Miller, PhD, Awarded $2.8 Million NHLB Grant to Research Coronary Artery Disease
7/16/2024
Clint L. Miller, PhD, an associate professor in the Department of Public Health Sciences and member of the Center of Public Health Genomics, was awarded a four-year $2.8 million grant…
7/16/2024
Anna Cliffe, PhD, an associate professor in the Department of Microbiology, Immunology, and Cancer Biology, was awarded a $3.3 million R01 grant from the National Institutes of Health for a…
Research in Motion: John Bushweller, PhD
7/16/2024
We're developing drugs targeting transcription factors. These are proteins that regulate gene expression in the cell; they are important drivers in specific types of cancer. —John Bushweller, PhD, Department of…
